Purchase Order HHSF223201810043A
- Not listed
- This is a $256,619.89 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The contract is for the provision of Bordetella-free weanling baboons. The award does not have a set-aside designation. The Texas Biomedical Research Institute is a leading independent biomedical research organization that specializes in infectious disease research, particularly...
- This federal contract award was made by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research, for the provision of weanling baboons. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $90,000.00 and an ultimate completion date of March 23, 2016. The contract was awarded on August 28, 2015 without any set-aside designation. The Texas Biomedical Research Institute is a leading...
- This $75,061 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation for Biomedical Research. The contract is for the provision of Bordetella-free weanling baboons. The contract was awarded on June 19, 2019 and has an ultimate completion date of October 17, 2019. The contract was not set aside and was awarded under a solicitation posted on May 16, 2019. The Texas Biomedical...
- This is a $541,578 firm fixed price purchase order issued by the Department of Health and Human Services Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The contract is for the delivery of Bordetella-free weanling baboons to support the FDA's Center for Biologics Evaluation and Research (CBER) research on pertussis disease and vaccines. The contract has no set-aside designation. The Texas...
- This federal contract award was made to the Texas Biomedical Research Institute, doing business as the Southwest Foundation for Biomedical Research, a non-profit biomedical research institute in San Antonio, Texas. The contract, which is a definitive, cost-no-fee contract, was awarded on June 15, 1992 with a potential value of $466,117.00. The contract does not have a set-aside designation. The contract supports the Texas Biomedical Research Institute's work in areas such as infectious disease...
- This is a $4,722,966.14 firm fixed-price definitive contract awarded by the Joint PEO Chemical and Biological Defense to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The contract, which does not have a set-aside designation, supports the development and refinement of animal and animal replacement models for evaluating candidate countermeasures against infectious agents with pandemic potential. The institute operates the Southwest...
- The Department of Health and Human Services Food and Drug Administration awarded a $193,026 firm fixed price purchase order to Texas Biomedical Research Institute, doing business as Southwest Foundation For Biomedical Research. The purpose of this contract is to obtain baboons for an OMV-pertussis vaccine study to be conducted at the FDA/CBER facility in Silver Spring, Maryland. Performance will take place in San Antonio, Texas over a one year period concluding in late September 2024. No...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $237,920.72 firm fixed price purchase order to Texas Biomedical Research Institute (also doing business as Southwest Foundation for Biomedical Research) for a baboon study. The contract was awarded on September 15, 2022, with an ultimate completion date of September 14, 2023, and performance will be conducted at the awardee's facility in San Antonio, Texas. No set-aside designation was applied to this award. Texas...
- This is a $12,664.08 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the Texas Biomedical Research Institute, doing business as Southwest Foundation For Biomedical Research. The contract is for research services to assay the effect of drug and control on Ebola virus infection of cells under biosafety level 4 conditions, including collecting supernatants and measuring...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Child Health and Human Development awarded a $852,694 fixed-price redetermination contract to the Texas Biomedical Research Institute, doing business as the Southwest Foundation for Biomedical Research, for the maintenance and operation of a chemical synthesis facility. The contract does not have a set-aside designation and was awarded on May 1, 2007 with a completion date of September 30,...
This federal contract award, valued at $179,084.58, was issued by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The contract is for the supply of Bordetella-free weanling baboons, which will be used for research purposes. The Texas Biomedical Research Institute is a leading independent biomedical research organization that specializes in infectious disease research, particularly focusing on HIV/AIDS, tuberculosis, malaria, and emerging pathogens. The institute operates the Southwest National Primate Research Center, one of seven National Institutes of Health (NIH)-funded national primate research centers in the United States, which enables it to conduct cutting-edge research using non-human primate models. This contract award is not associated with a set-aside designation, reflecting the institute's specialized expertise in biomedical research. The Texas Biomedical Research Institute also holds two significant federal contract Indefinite Delivery Vehicles (IDVs) from the National Institute of Allergy and Infectious Diseases (NIAID) and the Office of the Assistant Secretary for Preparedness and Response, demonstrating its critical role in supporting federal efforts to enhance pandemic preparedness and response capabilities.